The poor prognostic effect of MCM3 overexpression was also shown in gliomas, thyroid carcinomas, melanoma, cutaneous T-cell lymphomas and oral squamous cell carcinomas.19 This evidence concerns the gene MCM3 and thyroid gland carcinoma.